Abstract
Abstract: Sars – Cov-2 infection has been associated with clinical manifestations not only immunological, but also coagulative. A series of serological markers can increase its concentration when there is the presence of Thromboembolism (PTE) in patients with COVID-19, such as D-dimer, cardiac markers including cerebral natriuretic peptide, creatine kinase and troponin T. The immune factors that contribute to COVID-19 intravascular coagulopathy are: diffuse damage and alveolar inflammation; diffuse interstitial inflammation, extensive activation of pulmonary macrophages, dysregulation of innate pulmonary immune responses (eg, down regulation of angiotensin 2-converting enzyme receptor expression), adaptive immune responses to COVID-19, activation of innate immunity with advanced age and age-related coagulation cascade changes. This article shows a case report of a patient with COVID-19 and Pulmonary Thromboembolism, correlating the aspects observed in the patient's image and clinic with the current literature. Keywords: Coronavirus infections, Pulmonary embolism, Tomography.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
